Skip to main navigation Skip to search Skip to main content

Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months follow-up

  • Iddo Z. Ben-Dov
  • , Yonatan Oster
  • , Keren Tzukert
  • , Talia Alster
  • , Raneem Bader
  • , Ruth Israeli
  • , Haya Asayag
  • , Michal Aharon
  • , Ido Burstein
  • , Hadas Pri-Chen
  • , Ashraf Imam
  • , Roy Abel
  • , Irit Mor-Yosef Levi
  • , Abed Khalaileh
  • , Esther Oiknine-Djian
  • , Aharon Bloch
  • , Dana G. Wolf
  • , Michal Dranitzki Elhalel

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months follow-up'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry